Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland
· Delayed Price · Currency is CHF 12.20
+0.12 (0.99%)
At close: Dec 5, 2025
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 79 employees as of December 31, 2024. The number of employees increased by 34 or 75.22% compared to the previous year.
Employees
79
Change (1Y)
34
Growth (1Y)
75.22%
Revenue / Employee
620.46K CHF
Profits / Employee
-829.66K CHF
Market Cap
163.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Galderma Group AG | 6,545 |
| Lonza Group AG | 18,944 |
| Alcon | 25,599 |
| Sandoz Group AG | 22,049 |
| Straumann Holding AG | 11,815 |
| Sonova Holding AG | 18,366 |
Santhera Pharmaceuticals Holding AG News
- 4 weeks ago - Half Year 2025 Santhera Pharmaceuticals Holding AG Analyst Briefing Transcript - GuruFocus
- 2 months ago - Santhera Partners With Biomedica To Distribute Agamree In Russia - Nasdaq
- 2 months ago - Health Canada Approves Santhera's AGAMREE For Duchenne Muscular Dystrophy - Nasdaq
- 2 months ago - Santhera Pharmaceuticals Holding AG (SPHDF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Santhera Pharmaceuticals Holding AG 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Santhera Pharma Stock Down On Wider H1 Loss; Is AGAMREE On Track? - Nasdaq
- 3 months ago - Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE® (Vamorolone) in India - GlobeNewsWire
- 3 months ago - Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries - GlobeNewsWire